Hospital volumes for pediatric respiratory syncytial virus (RSV) rose significantly following the pandemic, along with the need for advanced respiratory support in older children with fewer comorbidities, according to a study published online June 13 in JAMA Network Open. Zachary A. Winthrop, M.D., from Boston Children’s Hospital, and colleagues analyzed demographics, respiratory support modes, and clinical outcomes of children with RSV infections at tertiary pediatric hospitals (2017 to 2023) using data from 288,816 children aged 5 years and younger treated for RSV at 48 freestanding U.S. children’s hospitals registered in Read More
